|
Delayed
Bombay S.E.
02:00:05 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 12.00 INR | +4.99% |
|
+6.19% | -66.33% |
| 08-12 | Bacil Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 07-10 | Bacil Pharma Limited Announces Board Resignations, Effective July 9, 2026 | CI |
| Market Cap | 685M 7.17M 6.16M 5.76M 5.28M 9.94M 9.97M 68.26M 26.68M 345M 26.93M 26.35M 1.14B | P/E 2024 |
-146x | P/E 2025 | 66.4x |
|---|---|---|---|---|---|
| Enterprise Value | 658M 6.89M 5.92M 5.54M 5.07M 9.55M 9.58M 65.58M 25.63M 332M 25.87M 25.31M 1.1B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
35.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +4.99% | ||
| 1 week | +6.19% | ||
| Current month | -45.08% | ||
| 1 month | -55.21% | ||
| 3 months | -76.37% | ||
| 6 months | -75.51% | ||
| Current year | -66.33% |
| 1 week | 11 |  | 12.9 |
| 1 month | 11 | | 26.79 |
| Current year | 11 | | 61.8 |
| 1 year | 11 | | 61.8 |
| 3 years | 4.68 | | 62.56 |
| 5 years | 3.67 | | 62.56 |
| 10 years | 1.57 | | 62.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 2025-07-15 | |
| Corporate Secretary | - | 2025-12-18 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2025-07-15 | |
| Director/Board Member | 70 | 1990-08-08 | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.99% | +6.19% | -65.77% | +53.45% | 1.72M | |
| -1.12% | -5.49% | +60.19% | +112.43% | 1,048B | |
| -1.57% | -0.60% | +50.33% | +59.86% | 640B | |
| -1.81% | -1.41% | +24.07% | +75.98% | 456B | |
| -1.17% | -2.10% | +38.61% | +40.43% | 362B | |
| -2.00% | -1.35% | +22.22% | +38.92% | 295B | |
| -0.98% | +0.53% | +2.04% | +12.13% | 255B | |
| -0.76% | +0.75% | +51.75% | +70.45% | 236B | |
| -3.18% | -0.30% | -17.23% | -53.79% | 204B | |
| +0.52% | +3.78% | +30.67% | +93.68% | 185B | |
| Average | -0.71% | -1.01% | +19.69% | +50.35% | 368.16B | |
| Weighted average by Cap. | -1.36% | -1.92% | +38.50% | +66.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -590K -6.18K -5.31K -4.97K -4.55K -8.57K -8.6K -58.84K -23K -298K -23.21K -22.71K -985K | 4.04M 42.31K 36.32K 34K 31.14K 58.66K 58.82K 403K 157K 2.04M 159K 155K 6.74M |
| Net Debt | 570K 5.96K 5.12K 4.79K 4.39K 8.27K 8.29K 56.75K 22.18K 287K 22.39K 21.9K 950K | -26.93M -282K -242K -227K -208K -391K -392K -2.68M -1.05M -13.57M -1.06M -1.04M -44.93M |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | ₹12.00 | +4.99% | 62,334 |
| 26-08-27 | ₹11.43 | -1.64% | 27,155 |
| 26-08-26 | ₹11.62 | +3.66% | 39,026 |
| 26-08-25 | ₹11.21 | -4.84% | 90,655 |
| 26-08-24 | ₹11.78 | -4.23% | 96,630 |
- Stock Market
- Stocks
- BACPHAR6 Stock
Select your edition
All financial news and data tailored to specific country editions
